Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study-Reference-Cited by-同舟云学术

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

Published:2015-01 Issue:1 Volume:16 Page:57-66
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Topp Max S,Gökbuget Nicola,Stein Anthony S,Zugmaier Gerhard,O'Brien Susan,Bargou Ralf C,Dombret Hervé,Fielding Adele K,Heffner Leonard,Larson Richard A,Neumann Svenja,Foà Robin,Litzow Mark,Ribera Josep-Maria,Rambaldi Alessandro,Schiller Gary,Brüggemann Monika,Horst Heinz A,Holland Chris,Jia Catherine,Maniar Tapan,Huber Birgit,Nagorsen Dirk,Forman Stephen J,Kantarjian Hagop M

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study;Fielding;Blood,2007

2. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation;Gökbuget;Blood,2012

3. Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration;Kantarjian;Cancer,2010

4. Outcome of adults with acute lymphocytic leukemia after second salvage therapy;O'Brien;Cancer,2008

5. Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group;Oriol;Haematologica,2010

Cited by 1047 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers;JAMA Oncology;2024-08-29

2. Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children’s Cancer Group;International Journal of Hematology;2024-08-27

3. The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia;Leukemia & Lymphoma;2024-08-18

4. CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing;Communications Biology;2024-08-13

5. Therapeutic potential of cis-targeting bispecific antibodies;Cell Chemical Biology;2024-08